Literature DB >> 18591372

Applying case definition criteria to irritable bowel syndrome.

Steven H Yale1, A Kenneth Musana, Amy Kieke, Jennifer Hayes, Ingrid Glurich, Po-Huang Chyou.   

Abstract

OBJECTIVE: The quality of documentation of signs and symptoms and validation of the diagnosis of irritable bowel syndrome (IBS) according to case definition criteria of Manning, Rome I and Rome II in an office setting has not been previously described. We sought to identify and validate cases of IBS based on the Manning, Rome I and Rome II diagnostic criteria in a rural practice setting.
SETTING: Marshfield Epidemiologic Study Area (MESA) Central consisting of 14 ZIP codes in central Wisconsin, USA.
METHODS: A retrospective cohort study involved 890 patients with the diagnostic codes 564.1 for irritable bowel syndrome and 306.4 spastic colon-psychogenic who had presented to the practice from 1993-2003. Duration, frequency, concordance and intensity of symptoms based on case definitions of IBS were abstracted from the medical records.
RESULTS: During the study period, 890 incident cases of IBS were identified. Only 404 met one or more of the three diagnostic criteria, 340 (84%) met only the Manning criteria, 35 (10%) met only Manning and Rome I criteria, 4 (1%) met both Manning and Rome II criteria, and 25 (6%) met Manning and Rome I and Rome II criteria. Age adjusted incidence rates per 100,000 person-years for validated IBS cases during the observational period were 87 to 170 by Manning (lower confidence interval [CI]: 57-127, upper CI: 116-213), 8 to 34 (lower CI: 0-14, upper CI: 16-53) for Rome I and 3 to 16 (lower CI: 0-3, upper CI: 8-28) for Rome II. Comparison of Rome I and Rome II showed moderate concordance (kappa statistic = 0.51; 95% CI: 0.39-0.64).
CONCLUSIONS: Only a small percentage of IBS cases with assigned diagnostic codes met case definition criteria for IBS. There were low concordance rates among the three diagnostic criteria applied.

Entities:  

Mesh:

Year:  2008        PMID: 18591372      PMCID: PMC2442028          DOI: 10.3121/cmr.2008.788

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  35 in total

Review 1.  The irritable bowel syndrome.

Authors:  B J Horwitz; R S Fisher
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

2.  Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?

Authors:  P M Boyce; N A Koloski; N J Talley
Journal:  Am J Gastroenterol       Date:  2000-11       Impact factor: 10.864

Review 3.  Irritable bowel syndrome.

Authors:  Y Ringel; A D Sperber; D A Drossman
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

4.  Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population.

Authors:  F Mearin; X Badía; A Balboa; E Baró; E Caldwell; M Cucala; M Díaz-Rubio; A Fueyo; J Ponce; M Roset; N J Talley
Journal:  Scand J Gastroenterol       Date:  2001-11       Impact factor: 2.423

5.  A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome.

Authors:  Y A Saito; G R Locke; N J Talley; A R Zinsmeister; S L Fett; L J Melton
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

6.  Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women.

Authors:  William D Chey; Kevin Olden; Eric Carter; John Boyle; Douglas Drossman; Lin Chang
Journal:  Am J Gastroenterol       Date:  2002-11       Impact factor: 10.864

7.  Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study.

Authors:  N J Talley; G Holtmann; L Agréus; M Jones
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

8.  Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome.

Authors:  L A García Rodríguez; A Ruigómez; M A Wallander; S Johansson; L Olbe
Journal:  Scand J Gastroenterol       Date:  2000-03       Impact factor: 2.423

9.  Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire.

Authors:  W G Thompson; E J Irvine; P Pare; S Ferrazzi; L Rance
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

Review 10.  Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome.

Authors:  M Camilleri; R C Heading; W G Thompson
Journal:  Aliment Pharmacol Ther       Date:  2002-08       Impact factor: 8.171

View more
  10 in total

1.  Deployment-associated functional gastrointestinal disorders: do we know the etiology?

Authors:  Ashok K Tuteja
Journal:  Dig Dis Sci       Date:  2011-11       Impact factor: 3.199

2.  Irritable bowel syndrome and inflammatory bowel disease: infectious gastroenteritis-related disorders?

Authors:  Shunji Ishihara; Monowar Aziz; Naoki Oshima; Yoshiyuki Mishima; Hiroshi Imaoka; Ichiro Moriyama; Yoshikazu Kinoshita
Journal:  Clin J Gastroenterol       Date:  2009-01-06

3.  Increased risk for irritable bowel syndrome after acute diverticulitis.

Authors:  Erica Cohen; Garth Fuller; Roger Bolus; Rusha Modi; Michelle Vu; Kamyar Shahedi; Rena Shah; Mary Atia; Nicole Kurzbard; Victoria Sheen; Nikhil Agarwal; Marc Kaneshiro; Linnette Yen; Paul Hodgkins; M Haim Erder; Brennan Spiegel
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-21       Impact factor: 11.382

4.  Comparing administrative and survey data for ascertaining cases of irritable bowel syndrome: a population-based investigation.

Authors:  Lisa M Lix; Marina S Yogendran; Souradet Y Shaw; Laura E Targownick; Jennifer Jones; Osama Bataineh
Journal:  BMC Health Serv Res       Date:  2010-02-01       Impact factor: 2.655

5.  Presacral schwannoma treated as irritable bowel syndrome.

Authors:  Triq Habib; Jamal T Hamdi; Waleed Hussain; Wail Almiamini; Khaled Hamdi; Abdul Majid Wani; Najah Rashid Al Zeyani
Journal:  BMJ Case Rep       Date:  2010-09-19

6.  Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study.

Authors:  M Nørgaard; D K Farkas; L Pedersen; R Erichsen; Z D de la Cour; H Gregersen; H T Sørensen
Journal:  Br J Cancer       Date:  2011-02-22       Impact factor: 7.640

Review 7.  The search for reliable biomarkers of disease in multiple chemical sensitivity and other environmental intolerances.

Authors:  Chiara De Luca; Desanka Raskovic; Valeria Pacifico; Jeffrey Chung Sheun Thai; Liudmila Korkina
Journal:  Int J Environ Res Public Health       Date:  2011-07-01       Impact factor: 3.390

8.  GP perspectives of irritable bowel syndrome--an accepted illness, but management deviates from guidelines: a qualitative study.

Authors:  Elaine F Harkness; Val Harrington; Sue Hinder; Sarah J O'Brien; David G Thompson; Paula Beech; Carolyn A Chew-Graham
Journal:  BMC Fam Pract       Date:  2013-06-27       Impact factor: 2.497

9.  Cumin extract for symptom control in patients with irritable bowel syndrome: a case series.

Authors:  Shahram Agah; Amir Mehdi Taleb; Reyhane Moeini; Narjes Gorji; Hajar Nikbakht
Journal:  Middle East J Dig Dis       Date:  2013-10

10.  Using read codes to identify patients with irritable bowel syndrome in general practice: a database study.

Authors:  Elaine F Harkness; Laura Grant; Sarah J O'Brien; Carolyn A Chew-Graham; David G Thompson
Journal:  BMC Fam Pract       Date:  2013-12-02       Impact factor: 2.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.